VAERS reports by lot

Moderna COVID-19 lot 02L20A: VAERS reports

34 VAERS reports list lot 02L20A as a Moderna COVID-19 vaccine, received between 2021-01-01 and 2023-06-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
34
Reports
3%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2621%
Dermatological (non-injection-site)2117%
Musculoskeletal1613%
Neurological1412%
Injection-site / Local reaction119%
Cardiac / Cardiovascular87%
Respiratory65%
Gastrointestinal65%
Allergic / Anaphylactic54%
Psychiatric / Neuropsychiatric43%
Reproductive / Menstrual32%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Indiana3
New York3
California3
Mississippi2
Texas2
North Carolina2
Illinois2
Ohio1
Rhode Island1
Virginia1
Iowa1

Reports by month received

2021-0115
2021-027
2021-033
2021-042
2021-084
2022-092
2023-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.